Qiagen Says China Study Supports QuantiFERON-TB Gold Tuberculosis Test
This article was originally published in The Gray Sheet
Executive Summary
Results of a major trial in China show that results from traditional tuberculin skin tests often overestimate the prevalence of latent tuberculosis in China. Qiagen says the study supports screening high-risk populations with interferon-γ release assays like its QuantiFERON-TB Gold to reduce tuberculosis incidence.